Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023

Rhea-AI Summary

Moderna, Inc. (NASDAQ:MRNA) will host its Vaccines Day for analysts and investors on April 11, 2023, at 8:00 a.m. ET. The event aims to showcase presentations on its mRNA vaccines and essential vaccine development insights from management and key opinion leaders. The presentation will be available via a live webcast and can be accessed later on Moderna's website. Over the past decade, Moderna has evolved from a research-stage entity to a leading biotechnology company, recognized for its groundbreaking mRNA therapeutics and vaccines, including significant contributions to COVID-19 vaccination efforts.

CAMBRIDGE, MA / ACCESSWIRE / March 24, 2023 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it will present its Vaccines Day for analysts and investors at 8:00 a.m. ET on Tuesday, April 11, 2023.

Moderna's Vaccines Day will include presentations from management and key opinion leaders (KOLs) on Moderna's mRNA vaccines and key considerations for vaccine development. A live webcast will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of the webcast will be archived on Moderna's website for one year following the presentation.

About Moderna

In over 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio and integrated manufacturing facilities that allow for rapid clinical and commercial production at scale. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna's capabilities have come together to allow the authorized use and approval of one of the earliest and most effective vaccines against the COVID pandemic.

Moderna's mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Moderna has been named a top biopharmaceutical employer by Science for the past eight years. To learn more, visit www.modernatx.com

Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com

SOURCE: Moderna, Inc.

View source version on accesswire.com:
https://www.accesswire.com/743659/Moderna-to-Host-Fourth-Annual-Virtual-Vaccines-Day-on-April-11-2023

FAQ

What is Moderna's Vaccines Day event?

Moderna's Vaccines Day is an event planned for April 11, 2023, focused on presenting insights into its mRNA vaccines and vaccine development.

When will Moderna's Vaccines Day take place?

The Vaccines Day event will be held on April 11, 2023, at 8:00 a.m. ET.

How can I watch Moderna's Vaccines Day presentations?

The presentations will be available via a live webcast on Moderna's investor website.

What company is hosting the Vaccines Day event?

The event is hosted by Moderna, Inc. (NASDAQ:MRNA), a leading biotechnology company.

Why is Moderna significant in the biotechnology field?

Moderna is known for pioneering mRNA vaccines and therapeutics, significantly impacting COVID-19 vaccination and other disease treatments.